<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="134505">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on April 10, 2017</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01350674</url>
  </required_header>
  <id_info>
    <org_study_id>B07620109427</org_study_id>
    <secondary_id>AK/10-10-3949/67</secondary_id>
    <nct_id>NCT01350674</nct_id>
  </id_info>
  <brief_title>Role of EBUS-TBNA in Diagnosing TB in Mediastinal/Hilar Lymph Nodes</brief_title>
  <official_title>Role of EBUS-TBNA (Endobronchial Ultrasound Transbronchial Needle Aspiration- in Diagnosing Tuberculosis in Mediastinal and/or Hilar Lymph Nodes</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Centre Hospitalier Universitaire Saint Pierre</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Centre Hospitalier Universitaire Saint Pierre</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This is an observational prospective study. Role of EBUS-TBNA (endobronchial ultrasound
      transbronchial needle aspiration) is evaluated to diagnose tuberculosis in mediastinal
      and/or hilar lymph nodes.

      The investigators analyse the specificity and sensibility of this technique to diagnose
      tuberculosis in mediastinal and/or hilar lymph nodes.

      Patients with mediastinal and/or hilar lymph nodes on X-ray or CT thorax where a
      tuberculosis is the most probable cause and who have no parenchymal lesions suspected for
      tuberculosis and without other lymph nodes that are more easily accessible or palpable will
      be included in this study.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>December 2010</start_date>
  <completion_date type="Anticipated">March 2016</completion_date>
  <primary_completion_date type="Anticipated">December 2015</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Diagnostic</primary_purpose>
    <masking>Open Label</masking>
  </study_design_info>
  <primary_outcome>
    <measure>The ratio of tuberculosis in mediastinal lymph nodes</measure>
    <time_frame>8 weeks</time_frame>
  </primary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">50</enrollment>
  <condition>Tuberculosis</condition>
  <arm_group>
    <arm_group_label>EBUS</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>patients undergoing EBUS</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>EBUS-TBNA</intervention_name>
    <description>endobronchial ultrasound transbronchial needle aspiration</description>
    <arm_group_label>EBUS</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  patients with enlarged mediastinal and/or hilar lymph nodes on chest CT highly
             suspicious of tuberculosis (suggestive clinical history, suggestive echographic
             findings ...) without pulmonary lesions suspicious for tuberculosis or in whom the
             first evaluation with sputum examination, classical bronchoscopy, induced sputum
             didn't result in any diagnosis.

          -  patients aged 18 years or older

          -  patients need to sign the consent form after reading the information form

        Exclusion Criteria:

          -  synchronic pulmonary lesions suspicious for tuberculosis or already proven
             tuberculosis by microscopic exam, PCR-technique and/or culture

          -  other affected ganglionary sites more easily accessible (cervical, supraclavicular,
             axillary ... region)
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Inge M Muylle, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>CHU St. Pierre Brussels</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Inge M Muylle, MD</last_name>
    <phone>+3225354295</phone>
    <email>inge_muylle@stpieter-bru.be</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Vincent Ninane, PhD MD</last_name>
    <phone>+3225354276</phone>
    <email>vincent_ninane@stpierre-bru.be</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>CHU St. Pierre; pulmonology department</name>
      <address>
        <city>Brussels</city>
        <zip>1000</zip>
        <country>Belgium</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Inge M Muylle, MD</last_name>
      <phone>+3225354295</phone>
      <email>inge_muylle@stpieter-bru.be</email>
    </contact>
    <contact_backup>
      <last_name>Vincent Ninane, PhD, MD</last_name>
      <phone>+3225354276</phone>
      <email>vincent_ninane@stpierre-bru.be</email>
    </contact_backup>
    <investigator>
      <last_name>Inge M Muylle, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Belgium</country>
  </location_countries>
  <verification_date>August 2015</verification_date>
  <lastchanged_date>August 7, 2015</lastchanged_date>
  <firstreceived_date>April 28, 2011</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>mediastinal tuberculosis</keyword>
  <keyword>endoscopy</keyword>
  <keyword>EBUS</keyword>
  <keyword>tuberculous lymphadenopathy</keyword>
  <keyword>endobronchial ultrasound</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Tuberculosis</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
